Our previous report revealed that the main group of non-TRU-type lung adenocarcinomas were hepatocyte nuclear factor 4α (HNF4α)-positive adenocarcinomas with gastrointestinal features that frequently harbored KRAS mutations and TTF-1 inactivating mutations/hypermethylation [11]. The gene discussed is KRAS; the disease is adenocarcinoma.